EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY

The study included 48 vitreoretinal surgeries performed during 2014-2015 in 39 patients with advanced fibrovascular stage of proliferative diabetic retinopathy. Visual acuity before the surgery averaged from pr. l. certae to 0.01. In 7 cases patients underwent intravitreal injection of Lucentis 2-3...

Full description

Saved in:
Bibliographic Details
Main Authors: O. M. Trubina, V. N. Kanyukov, A. N. Kazennov, I. A. Kazennova
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2016-11-01
Series:Acta Biomedica Scientifica
Subjects:
Online Access:https://www.actabiomedica.ru/jour/article/view/332
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849251601304256512
author O. M. Trubina
V. N. Kanyukov
A. N. Kazennov
I. A. Kazennova
author_facet O. M. Trubina
V. N. Kanyukov
A. N. Kazennov
I. A. Kazennova
author_sort O. M. Trubina
collection DOAJ
description The study included 48 vitreoretinal surgeries performed during 2014-2015 in 39 patients with advanced fibrovascular stage of proliferative diabetic retinopathy. Visual acuity before the surgery averaged from pr. l. certae to 0.01. In 7 cases patients underwent intravitreal injection of Lucentis 2-3 weeks before the surgery. The surgery was performed according to the standard 3-port 25 G vitrectomy. In some cases, short-term tamponade of vitreous cavity by fluid perfluororganic compounds (PFOS) was performed for 2-3 days. This was due to prolonged bleeding during the surgery. In these cases, fibrinolytic of direct action (hemasa) was injected directly to the blood clot. In 4 cases circular retinotomy was needed. In 35 cases tamponade was made by silicone oil 5700 cSt, in 13 - by air-gas mixture. In cases of air-gas tamponade 3 patients had a relapse. After vitreous cavity revision it was plugged with silicone oil 5700 cSt. In 17 cases visual function remained unchanged, in 18 cases the changes were imperceptible, in 9 cases visual acuity improved to 0.2, in 3 cases -visual function increased to 0.4 and in 1 patient - to 0.7. In postoperative period IOP increased in 7 cases. In 5 of these cases compensation was achieved with antihypertensive drugs. 1n one case the patient was implanted leukosapphire drainage, and in one more case transscleral cyclophotocoagulation about terminal aching glaucoma was performed. The silicone oil was removed in 6 patients at the period of 6 months up to 2 years.
format Article
id doaj-art-cb919caf2ab345469a6ed616e8a08e8c
institution Kabale University
issn 2541-9420
2587-9596
language Russian
publishDate 2016-11-01
publisher Scientific Сentre for Family Health and Human Reproduction Problems
record_format Article
series Acta Biomedica Scientifica
spelling doaj-art-cb919caf2ab345469a6ed616e8a08e8c2025-08-20T03:56:54ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962016-11-011611812110.12737/23791332EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHYO. M. Trubina0V. N. Kanyukov1A. N. Kazennov2I. A. Kazennova3Оренбургский филиал ФГАУ «МНТК «Микрохирургия глаза» им. акад. С.Н. Федорова» МЗ РФОренбургский филиал ФГАУ «МНТК «Микрохирургия глаза» им. акад. С.Н. Федорова» МЗ РФОренбургский филиал ФГАУ «МНТК «Микрохирургия глаза» им. акад. С.Н. Федорова» МЗ РФОренбургский филиал ФГАУ «МНТК «Микрохирургия глаза» им. акад. С.Н. Федорова» МЗ РФThe study included 48 vitreoretinal surgeries performed during 2014-2015 in 39 patients with advanced fibrovascular stage of proliferative diabetic retinopathy. Visual acuity before the surgery averaged from pr. l. certae to 0.01. In 7 cases patients underwent intravitreal injection of Lucentis 2-3 weeks before the surgery. The surgery was performed according to the standard 3-port 25 G vitrectomy. In some cases, short-term tamponade of vitreous cavity by fluid perfluororganic compounds (PFOS) was performed for 2-3 days. This was due to prolonged bleeding during the surgery. In these cases, fibrinolytic of direct action (hemasa) was injected directly to the blood clot. In 4 cases circular retinotomy was needed. In 35 cases tamponade was made by silicone oil 5700 cSt, in 13 - by air-gas mixture. In cases of air-gas tamponade 3 patients had a relapse. After vitreous cavity revision it was plugged with silicone oil 5700 cSt. In 17 cases visual function remained unchanged, in 18 cases the changes were imperceptible, in 9 cases visual acuity improved to 0.2, in 3 cases -visual function increased to 0.4 and in 1 patient - to 0.7. In postoperative period IOP increased in 7 cases. In 5 of these cases compensation was achieved with antihypertensive drugs. 1n one case the patient was implanted leukosapphire drainage, and in one more case transscleral cyclophotocoagulation about terminal aching glaucoma was performed. The silicone oil was removed in 6 patients at the period of 6 months up to 2 years.https://www.actabiomedica.ru/jour/article/view/332diabetes mellitusproliferative diabetic retinopathyvitrectomysilicone oillucentis
spellingShingle O. M. Trubina
V. N. Kanyukov
A. N. Kazennov
I. A. Kazennova
EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
Acta Biomedica Scientifica
diabetes mellitus
proliferative diabetic retinopathy
vitrectomy
silicone oil
lucentis
title EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
title_full EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
title_fullStr EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
title_full_unstemmed EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
title_short EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
title_sort experience of surgical treatment of proliferative diabetic retinopathy
topic diabetes mellitus
proliferative diabetic retinopathy
vitrectomy
silicone oil
lucentis
url https://www.actabiomedica.ru/jour/article/view/332
work_keys_str_mv AT omtrubina experienceofsurgicaltreatmentofproliferativediabeticretinopathy
AT vnkanyukov experienceofsurgicaltreatmentofproliferativediabeticretinopathy
AT ankazennov experienceofsurgicaltreatmentofproliferativediabeticretinopathy
AT iakazennova experienceofsurgicaltreatmentofproliferativediabeticretinopathy